Markus Meyer
Senior Vice President & Chief Medical Officer (CMO
cardiology
Cardiorentis
Switzerland
Biography
Professor Meyer has over two decades of clinical research experience. Prior to joining Cardiorentis, he co-founded CardioPep Pharma GmbH which was acquired by Cardiorentis in 2010. At CardioPep he oversaw the pre-clinical and clinical studies that led to the development of Ularitide. For his research, he received multiple awards. Professor Meyer received his M.D. from Heidelberg Medical School and currently serves as an Adjunct Professor at Hannover University School of Medicine.
Research Interest
Cardiology
